These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9835413)

  • 21. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems in maintaining hybridomas in vivo].
    Volgareva GM; Sviridov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):90-3. PubMed ID: 3551419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Technics of monoclonal antibody production with hybridomas and their medical application].
    Yamamoto K; Nakauchi H; Okumura K
    Nihon Rinsho; 1981; 39(12):3788-95. PubMed ID: 7040735
    [No Abstract]   [Full Text] [Related]  

  • 24. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
    J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of in vitro immunisation, as an adjunct to monoclonal antibody production, may result in the production of hybridomas secreting polyreactive antibodies.
    McMahon MJ; O'Kennedy R
    J Immunol Methods; 2001 Dec; 258(1-2):27-36. PubMed ID: 11684120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General principles of the technic for obtaining monoclonal antibodies].
    Favila Castillo L; Velázquez García P
    Salud Publica Mex; 1985; 27(3):185-93. PubMed ID: 3901314
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of monoclonal antibodies.
    Yokoyama WM
    Curr Protoc Cell Biol; 2001 May; Chapter 16():Unit 16.1. PubMed ID: 18228333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID).
    Ware CF; Donato NJ; Dorshkind K
    J Immunol Methods; 1985 Dec; 85(2):353-61. PubMed ID: 4078317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of mouse hybridomas.
    Mechetner E
    Methods Mol Biol; 2007; 378():1-13. PubMed ID: 18605074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
    Spieker-Polet H; Sethupathi P; Yam PC; Knight KL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9348-52. PubMed ID: 7568130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of monoclonal antibodies in large-scale cell culture.
    Birch JR; Thompson PW; Boraston R
    Biochem Soc Trans; 1985 Feb; 13(1):10-2. PubMed ID: 3888719
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies.
    Zhao X
    Methods Mol Biol; 1995; 45():61-7. PubMed ID: 7550693
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of monoclonal antibody in mouse ascitic fluid with two solid tumor-forming hybridoma cell lines.
    Hasegawa N; Watanabe M; Okano HJ; Ohno T
    Hybridoma; 1991 Oct; 10(5):647-9. PubMed ID: 1804776
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibody production in murine ascites. I. Clinical and pathologic features.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):70-80. PubMed ID: 10090098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 37. Production kinetics of monoclonal antibodies.
    Merten OW; Reiter S; Himmler G; Scheirer W; Katinger H
    Dev Biol Stand; 1985; 60():219-27. PubMed ID: 3899782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of stable heterohybridomas producing human monoclonal antibodies.
    Cooper MD; Kirkpatrick R
    Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential effects of immunosuppressants and antibiotics on human monoclonal antibody production in SCID mouse ascites by five heterohybridomas.
    Yoshinari K; Arai K
    Hybridoma; 1998 Feb; 17(1):41-5. PubMed ID: 9523236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat monoclonal antibodies. VI. Production of IgA secreting hybridomas with specificity for the 2,4-dinitrophenyl (DNP) hapten.
    Rits M; Cormont F; Bazin H; Meykens R; Vaerman JP
    J Immunol Methods; 1986 May; 89(1):81-7. PubMed ID: 3701070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.